Kathleen Seyb
Intarcia Therapeutics (United States)(US)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Complement system in diseases, Endoplasmic Reticulum Stress and Disease, Cholinesterase and Neurodegenerative Diseases, Neuroscience and Neuropharmacology Research
Most-Cited Works
- → Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection(2014)155 cited
- → Inhibitor of the Tyrosine Phosphatase STEP Reverses Cognitive Deficits in a Mouse Model of Alzheimer's Disease(2014)142 cited
- → Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based Design(2020)120 cited
- → β-Amyloid-Induced Neurodegeneration and Protection by Structurally Diverse Microtubule-Stabilizing Agents(2005)91 cited
- → Identification of Translational Activators of Glial Glutamate Transporter EAAT2 through Cell-Based High-Throughput Screening: An Approach to Prevent Excitotoxicity(2010)83 cited
- → Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis(2019)51 cited
- → β-Amyloid and Endoplasmic Reticulum Stress Reponses in Primary Neurons: Effects of Drugs That Interact With the Cytoskeleton(2006)46 cited
- → Tetrandrine identified in a small molecule screen to activate mesenchymal stem cells for enhanced immunomodulation(2016)36 cited
- → Preclinical Evaluation of RA101495, a Potent Cyclic Peptide Inhibitor of C5 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria(2015)34 cited
- → Structure–activity relationship study of EphB3 receptor tyrosine kinase inhibitors(2009)29 cited